Matthew J Sims

US Patent:

20170081708, Mar 23, 2017

Filed:

Dec 2, 2016

Appl. No.:

15/367776

Inventors:

- Royal Oak MI, US
Matthew Sims - Troy MI, US

International Classification:

C12Q 1/68

Abstract:

A method for diagnosing increased risk of developing Methicillin-resistant (MRSA) hospital-acquired (HA-MRSA) or community-acquired MRSA (CA-MRSA) which includes obtaining a biological sample from a subject, detecting in the sample a single nucleotide polymorphism (SNP) in the FAM129B gene at position 17 of SEQ ID NO 1, and comparing the nucleotide at position 17 of SEQ ID NO. 1 in the sample with the nucleotide at position 17 in SEQ ID NO. 1, wherein an adenine at position 17 of SEQ ID NO. 1 in the sample indicates an increased risk of developing MRSA or CA-MRSA in the subject.

US Patent:

20140272966, Sep 18, 2014

Filed:

Mar 13, 2014

Appl. No.:

14/209090

Inventors:

- Royal Oak MI, US
Matthew Sims - Troy MI, US

Assignee:

William Beaumont Hospital - Royal Oak MI

International Classification:

C12Q 1/68

US Classification:

435 611, 536 2432, 536 2433

Abstract:

A method for diagnosing increased risk of developing Methicillin-resistant (MRSA) hospital-acquired (HA-MRSA) or community-acquired MRSA (CA-MRSA) which includes obtaining a biological sample from a subject, detecting in the sample a single nucleotide polymorphism (SNP) in the FAM129B gene at position 17 of SEQ ID NO 1, and comparing the nucleotide at position 17 of SEQ ID NO. 1 in the sample with the nucleotide at position 17 in SEQ ID NO. 1, wherein an adenine at position 17 of SEQ ID NO. 1 in the sample indicates an increased risk of developing MRSA or CA-MRSA in the subject.